Volume 31, Issue 148 (September & October 2023)                   J Adv Med Biomed Res 2023, 31(148): 464-471 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Fakheri E, Kazemi N, Moradi N, Mirzaei B. Bacterial Urinary Tract Infections in North West of Iran: A Cross- Sectional Study. J Adv Med Biomed Res 2023; 31 (148) :464-471
URL: http://journal.zums.ac.ir/article-1-7009-en.html
1- Student Research Committee University of Medical Sciences, Zanjan, Iran
2- Department of Life Technologies, University of Turku, Turku, Finland
3- Department of Medical Microbiology and Virology, School of Medicine, Zanjan University of Medical Science, Zanjan, Iran , dr.bahman.m@gmail.com
Full-Text [PDF 403 kb]   (939 Downloads)     |   Abstract (HTML)  (1726 Views)

Alarming resistance rates were observed in ampicillin and piperacillin, which should be taken into account in therapy guidelines in this area. Prevalence of resistant strains can be avoided by developing appropriate healthcare policies and community awareness.


Full-Text:   (552 Views)
Introduction
 

Nosocomial infections or healthcare-associated infections (HAIs) are infections that hospitalized patients acquire throughout their period of stay. Symptoms of the disease may appear during the hospitalization or after discharge from the hospital (1). Infections that appear after 48 to 72 hours are usually classified as nosocomial, and if the infection occurs less than 48 hours of hospitalization, it is likely that the patient might have obtained the infection during the administration process and may have been in the common phase of the disease (2). A recent meta-analysis conducted by Mohammadi et al., from 2001 to 2017, reported a 4.6% overall prevalence rate of HIAs in Iranian hospitals (3). A 2014 CDC report including 183 US hospitals and 11,282 hospitalized patients indicated that 4% of the patients suffered from one or more HAIs (4). This results in a rise in costs, length of recovery, disabilities and even death amongst patients and attaches great importance to development of regionally studied and validated diagnostic and therapeutic guidelines for these infections.
Bacteria are microorganisms that are found in various environments, especially in clinical settings. The ability of bacteria to cause hospital outbreaks and epidemics is indicative of the importance of these microorganisms. Bacteria are mainly labeled as opportunistic pathogens and can create various acquired infections in clinical settings including bacteremia, meningitis, surgical wound infections, urinary tract infections (UTIs), hospital-acquired pneumonia, etc. (5). UTIs are bacterial infections that affect various parts of the urinary tract. Physiologic and anatomic differences have made UTIs more prevalent among women than men; however, the prevalence rate is similar in elderly males and females (6). Infections of the lower urinary tract and the upper urinary tract are referred to as cystitis (bladder infection) and pyelonephritis (kidney infection), respectively (7). Symptoms of the lower urinary tract infections include frequent urination accompanied by pain (dysuria), while symptoms of pyelonephritis include fever, shivering and flank pain in addition to the symptoms of lower urinary tract infections (8). The main cause of both types of infections is uropathogenic Escherichia coli, a gram negative rod- shaped bacterium from the Enterobacteriaceae family (9). The increasing antibiotic resistance and the emergence of multidrug-resistant (MDR) and extensively-drug resistant (XDR) E. coli strains have led to a global health crisis. In most of the infections, the hospital environment is the source and reservoir and, in several studies, it has been observed that environmental pollution has been the source of sudden epidemics caused by bacterial infections (1). Bacteria play an important role in UTIs; therefore, it is necessary to be aware of their prevalence and the causative pathogens for better prognosis, rapid treatment and elimination of the infectious agents in clinical settings. This study aims to evaluate the prevalence of bacterial isolates involved in UTI samples and their antibiotics resistance pattern.

 

Materials and Methods

Sample Collection and Culture
A cross-sectional study was designed to analyze bacterial infections in a total number of 3582 urine samples collected from ambulatory and hospitalized patients in Valie-Asr hospital in Zanjan, Iran, from December 2016 to December 2018. Samples were initially cultured on MacConkey agar and blood agar (Lioflchem, Italy), according to standard bacteriological protocols and incubated at 37°C for 24 hours (10).
Identification of Bacterial Isolates
Bergeys̓ microbiology book guidelines were applied for isolate identification (10). Gram staining and conventional media and biochemical tests including catalase, oxidase, Sulfide Indole Motility (SIM), Triple Sugar Iron Agar (TSI), Methyl Red (MR)/Voges-Proskauer (VP), citrate, sensitivity to specific antibiotic disks, Mannitol Salt Agar, urease, Dnase, etc. (Merck, Germany) were used to confirm the growth of the bacteria.
Antibiotic Susceptibility Testing
Disk diffusion susceptibility tests were performed on all positive clinical cultures, according to Clinical Laboratory Standard Institute (CLSI) guidelines (11) using the disks (BD BBLTM Sensi DiscTM) containing amikacin (AN) (30 μg), ceftazidime (CAZ) (30 μg), cephalexin (30 μg), levofloxacin (LEV) (5 μg), piperacillin-tazobactam (PI 10 μg) ciprofloxacin (CP) (5 μg), imipenem (IMP) (10 μg), meropenem (MEN) (10 μg), gentamycin (GM) (10 μg), ampicillin (10 µg), ceftriaxone (CRO) (30 µg), cefotaxime (CTX) (30 µg), trimethoprim/sulfamethoxazole (SXT) (25 [1.25/23.75] µg), cefazolin (CZ), cefepime (FEP) (30 μg), nitrofurantoin (FM) (300 µg), oxacillin (CX) (30 μg), and vancomycin (30 µg) (only for gram positive bacteria)  (11). American Type Culture Collection (ATCC) standard reference strains (Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 29213) were used as controls.
Statistical Analysis
The obtained data were sorted and statistically analyzed in SPSS 26 (SPSS Inc., Chicago, IL, USA). Pearson’s chi-square test was used for variable comparison in independent groups and P-values less than 0.05 were considered significant.
Ethics approval and consent to participate

This study complies with ethical principles and the standards for conducting clinical research and is approved by The Ethics Committee of Zanjan University of Medical Sciences (IR.ZUMS.REC.1398.370).In the current study, all ethical guidelines including Ethics and Consent to participate from the parents have been collected.
 

 
Results

From December 2016 to December 2018, a total number of 6299 urinary, respiratory tract, blood, and stool culture tests were performed for the patients who referred to Valie-Asr Hospital Laboratory in Zanjan, Iran, including 3168 (50.3%) males and 3131 (49.7%) females. Urine culture was the most frequently requested culture (n=3582, 56.87%), followed by sputum (n=1058, 16.8%), blood (n=854, 13.4%) and stool (n=182, 2.9%) cultures. In this study, we analyzed microbial cultures of patients with bacterial infections of the urinary tract and the associated antimicrobial resistance patterns. The study population consisted of a total number of 3582 patients with positive urine cultures (85%), including 2006 (56%) females and 1576 (44%) males in the 0-99 age range. The study population mainly consisted of middle-aged and elderly patients (n=2228, 62.2%), followed by young adults (n=1021, 28.5%). Positive urine cultures were the least frequent among adolescents and children (n=333, 9.3%). The average age of the study population was 63.4 years. With 1275 positive bacterial growth results, the emergency ward had the highest positive culture ratio (35.6%), followed by the following wards: internal (17.8%, n=638), neurosurgery (16.9%, n=605), intensive care unit (11.8%, n=423), infectious diseases (10.4%, n=373), cardiology (3.7%, n=133), surgery (1.6%, n=57), coronary care unit (0.9%, n=32) oncology (0.7%, n=25), and ophthalmology (0.6%, n=21).
According to urine cultures results, E. coli and Staphylococcus epidermidis were the most frequently isolated gram negative and gram-positive bacteria from the urine samples with isolation rates of 53.43% and 15.99%, respectively. Table 1 reveals information on the prevalence of the isolated bacteria.


Table 1. Prevalence of isolated bacteria from the urine samples of a total number of 3582 patients with positive urine cultures.

Isolation frequency (N=3582)
Gram Negative Escherichia coli 53.43% (n=1914)
Serratia marcescens 5.38% (n=193)
Pseudomonas aeruginosa 4.52% (n=162)
Klebsiella pneumoniae 4.15% (n=149)
Acinetobacter baumanni 0.3% (n=11)
Citrobacter freundii 0.16% (n=6)
Morganella morganii 0.11% (n=4)
Proteus mirabilis 0.08% (n=3)
Gram Positive Staphylococcus epidermidis 15.99% (n=537)
Group D Streptococci 7.7% (n=279)
Staphylococcus saprophyticus 6.19% (n=222)
Lactobacillus acidophilus 1.2% (n=44)
Viridans streptococci 1% (n=36)
Staphylococcus aureus 0.6% (n=22)

Among gram negative bacteria, nitrofurantoin and vancomycin represented the lowest resistance rates at 25.27% and 26.74% respectively. Piperacillin showed the least efficacy with a resistance rate of 76.04%, followed by cefazolin which had a resistance rate of 74.94%. Antibiotic susceptibility results of the isolated gram-negative bacteria are demonstrated in Table 2.


Table 2. Antibiotic susceptibility pattern of the gram-negative bacteria isolated from 2442 urine samples of the clinical origin and the associated resistance rates.

E. coli S. marcescens P. aeruginosa K. pneumonia A. bumannii C. freundii M. morganii P. mirabilis Total (N) Resistance Rate (%)
Number (n) 1914 193 162 149 11 6 4 3 2442
Amikacin Sensitive 1178 19 47 63 2 4 3 2 1318 30.18
Intermediate 353 3 2 24 2 1 1 1 387
Resistant 383 171 113 62 7 1 0 0 737
Gentamycin Sensitive 1187 15 50 49 6 3 0 3 1313 42.67
Intermediate 76 3 3 2 1 1 1 0 87
Resistant 651 175 109 98 4 2 3 0 1042
Imipenem Sensitive 1417 19 36 83 2 0 4 2 1563 30.63
Intermediate 95 17 2 14 1 2 0 0 131
Resistant 402 157 124 52 8 4 0 1 748
Nitrofurantoin Sensitive 1531 10 130 18 1 1 2 0 1693 25.27
Intermediate 115 2 3 12 0 0 0 0 132
Resistant 268 181 29 119 10 5 2 3 617
Trimethoprim/Sulfamethoxazole Sensitive 670 11 4 31 0 2 2 2 722 67.94
Intermediate 57 2 1 1 0 0 0 0 61
Resistant 1187 180 157 117 11 4 2 1 1659
Ciprofloxacin Sensitive 804 19 36 32 0 4 4 3 902 62.57
Intermediate 4 2 5 1 0 0 0 0 12
Resistant 1106 172 121 116 11 2 0 0 1528
Cefepime Sensitive 957 10 47 47 5 4 2 1 1073 52.78
Intermediate 57 2 7 11 0 0 2 1 80
Resistant 900 181 108 91 6 2 0 1 1289
Ceftriaxone Sensitive 756 10 17 38 1 2 2 2 828 64.62
Intermediate 17 2 11 3 3 0 0 0 36
Resistant 1141 181 134 108 7 4 2 1 1578
Piperacillin Sensitive 459 10 37 21 1 0 2 3 533 76.04
Intermediate 38 2 4 3 2 2 1 0 52
Resistant 1417 181 121 125 8 4 1 0 1857
Cefazolin Sensitive 511 4 14 19 0 2 1 2 553 74.94
Intermediate 54 1 0 2 0 1 0 1 59
Resistant 1349 188 148 128 11 3 3 0 1830
Ceftazidime Sensitive 924 7 47 50 2 3 0 2 1035 51.68
Intermediate 118 3 11 12 0 1 0 0 145
Resistant 872 183 104 87 9 2 4 1 1262
Levofloxacin Sensitive 840 14 39 61 2 2 4 2 964 57.82
Intermediate 54 3 3 3 2 0 0 1 66
Resistant 1020 176 120 85 7 4 0 0 1412
Ampicillin Sensitive 717 19 41 47 6 2 2 3 837 53.77
Intermediate 239 7 1 43 1 1 0 0 292
Resistant 958 167 120 59 4 3 2 0 1313
Cefoxitin Sensitive 1311 8 21 89 5 5 2 2 1443 39.60
Intermediate 19 3 5 2 1 1 1 0 32
Resistant 584 182 136 58 5 0 1 1 967

Among gram positive bacteria, vancomycin and gentamicin showed more promise with respective resistance rates of 19.34% and 27.34%. The highest resistance was associated with ampicillin (68.61%) and Trimethoprim/Sulfamethoxazole (66.06%). Antibiotic susceptibility results of the isolated gram-positive bacteria are demonstrated in Table 3.


Table 3. Antibiotic susceptibility pattern of the gram-positive bacteria isolated from 1096 urine samples of the clinical origin and the associated resistance rates.

S. epidemidis Group D Streptococci S. saprohyticus Viridans streptococci S. aureus Total (N) Resistance rate (%)
Number (n) 537 279 222 36 22 1096
Amikacin Susceptible 326 93 57 5 8 489 46.99
Intermediate 74 10 7 1 0 92
Resistant 137 176 158 30 14 515
Gentamicin Susceptible 397 104 145 30 19 695 27.83
Intermediate 23 57 13 2 1 96
Resistant 117 118 64 4 2 305
Imipenem Susceptible 254 80 109 24 12 479 50.91
Intermediate 4 40 8 6 1 59
Resistant 279 159 105 6 9 558
Nitrofurantoin Susceptible 388 224 130 27 18 787 24.82
Intermediate 16 11 7 2 1 37
Resistant 133 44 85 7 3 272
Trimethoprim/
Sulfamethoxazole
Susceptible 191 84 43 20 12 350 66.06
Intermediate 12 1 8 1 0 22
Resistant 334 194 171 15 10 724
Ciprofloxacin Susceptible 219 73 65 18 12 387 59.58
Intermediate 24 11 14 2 5 56
Resistant 294 195 143 16 5 653
Piperacillin Susceptible 260 78 147 4 5 494 51.55
Intermediate 8 16 7 3 3 37
Resistant 269 185 68 29 14 565
Cefepime Susceptible 281 93 58 5 17 454 54.38
Intermediate 25 12 6 0 3 46
Resistant 231 174 158 31 2 596
Vancomycin Susceptible 517 176 119 31 19 862 19.34
Intermediate 12 6 3 0 1 22
Resistant 8 97 100 5 2 212
Cefazolin Susceptible 329 42 34 17 18 440 57.12
Intermediate 9 8 7 4 2 30
Resistant 199 229 181 15 2 626
Oxacillin Susceptible 134 164 22 12 15 347 63.32
Intermediate 11 33 4 6 1 55
Resistant 392 82 196 18 6 694
Ampicillin Susceptible 119 93 86 14 7 319 68.61
Intermediate 6 14 3 1 1 25
Resistant 412 172 133 21 14 752
Levofloxacin Susceptible 253 159 93 4 9 518 51.09
Intermediate 10 2 4 2 1 19
Resistant 274 118 125 30 13 560


 

Discussion

A total number of 3582 ambulatory and hospitalized patients with bacterial UTI were included in our study. The overall prevalence of UTI was significantly high (85%, P<0.001) among the patients with a urine culture request compared to several similar studies, which reported overall UTI prevalence of 12.1% to 45.32% (12-15). Even though this prevalence variation can be due to geographical and environmental factors, diagnostic methods applied in the study and the characteristics of the included patients such as personal hygiene standards and diet (15), high prevalence ratio in our study raises the concern of sufficiency of the quantity of microbiologic tests requested by the physicians in this clinical setting in Zanjan, Iran from 2016 to 2018.
Similar to other studies in this timeframe and as expected from the general epidemiology of UTIs (14), the female patients consisted the majority of the population in our study. Furthermore, a significant increase was observed in the prevalence of UTI with age, given that most of the patients were from the middle-aged and the elderly group (P=0.016). This can be explained by higher number of hospital admission, longer duration of stay and previous antibiotic therapy in the elderly. UTI incidence in women over 60 was 1.7 times higher than the overall incidence in females, putting this group at the highest risk. This result is similar to that of a study by Alós, which reported 20% and 11% UTI prevalence rates in women over 65 years and in the overall population, respectively (16).
Gram-negative bacteria were significantly more prevalent (68%) than gram positive-bacteria (32%) in this study (P<0.001) and E. coli was the pathogen behind more than half of the infections. This is in accordance with results from several other studies, which reported the dominance of gram-negative bacteria and especially E. coli in their study populations (12). The second most common gram-negative bacteria -S. marcescens- nevertheless, was not reported to be frequently isolated in UTIs in other studies, as normally, E. coli, K. pneumoniae, P. aeruginosa, Enterobacter, Citrobacter, P. mirabilis are the most common bacterial uropathogens (17). S. marcescens usually accounts for 1-2% of HAIs; however, its isolation rate was significantly higher in this study (5.38%) (P<0.001) (18). This reveals that even though S. marcescens rarely causes community-acquired infections, its importance should be taken into account in healthcare settings and as a nosocomial infection, which plays a critical role in hospital outbreaks.
S. epidermidis and group D streptococci were the most prevalent gram-positive bacteria in the patient population with respective prevalence rates of 15.99% and 7.7%. This result was consistent with previous literature reporting Enterococcus spp., Staphylococcus spp., and Streptococcus agalactiae as dominant gram-positive uropathogens. Gram-positive bacteria nevertheless, are more likely to be contaminants in the urine cultures and should be analyzed along with other factors including symptoms and urine analysis results such as WBC count (19, 20). Lactobacilli-containing samples were excluded from antibiotic susceptibility tests since they are a part of vaginal bacterial flora and commonly indicative of contamination while collecting urine specimens (21).
Gram-negative bacteria were the most sensitive and resistant to nitrofurantoin and piperacillin with resistance rates of 25.27% and 76.04%, respectively. Gram-positive bacteria were widely resistant to ampicillin (68.61%) and Trimethoprim/Sulfamethoxazole (66.06%).
These results are in line with resistance patterns reported from Iran and worldwide (3, 12, 17, 22, 23). Vancomycin resistance was relatively low in both gram-negative (26.74%) and gram-positive (19.34%) bacteria. However, it is considered as a last-resort antibiotic and should only be included in the antibiotic therapy regimen according to regional guidelines and only when needed. The vancomycin resistance result in our study was higher compared to that of a UTI study conducted by Mihankhah et al., in northern Iran, in the same timeframe (11.7%) (22). Furthermore, in a study by Khoshbakht et al., conducted in Karaj, Iran in 2013, vancomycin resistance was reported 7.7% (24). This rate was reported lower and under 5% in a ten-year surveillance European study conducted on the prevalence and susceptibility patterns of UTI-associated bacteria, in 2013 (13).
The limitations of the study included exclusive application of conventional biochemical microbiological tests for bacterial identification and not determining resistance-associated genes.


 

Conclusion

The overall prevalence of UTIs was relatively high in this study, which emphasizes the importance of proper quantity and quality of urine cultures and susceptibility tests, as well as development of novel efficient surveillance guidelines for each area. E. coli and S. epidermidis were the most prevalently isolated uropathogens and there was a notable S. marcescens outbreak in the study timeframe. Alarming resistance rates were observed in ampicillin and piperacillin, which should be taken into account in therapy guidelines in this area. Prevalence of resistant strains can be avoided by developing appropriate healthcare policies and community awareness. Further studies should focus on regional and periodical prevalence and susceptibility patterns of the UTIs, globally.

 

Limitations

Responsible genes to antibiotic resistance, genetic relationship between the resistant strains, and investigating any correlations with patient characteristics are not determined and these are the limitations of this study. Moreover, identification of isolates were merely performed taking advantage of biochemical aspect.

 

Consent for publication

All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.

 

Funding

All data generated or analyzed during this study are included in this published article/as
supplementary information files.


 

Funding

Not applicable.

 

Authors’ Contributions

Supervision, methodology, final editing and review were done by Bahman Mirzaei. Bahman Mirzaei and Erfan Fakheri contributed to Conceptualization. Narges Moradi and Niloufar Kazemi contributed to data collection, writing and data curation.

 

Acknowledgements

The authors are grateful for the support of colleagues in Bacteriology and virology Departments at Zanjan University of Medical Sciences.

 

Conflicts of Interest

The authors declare that they have no competing interests.

 

Type of Study: Original Research Article | Subject: Clinical Medicine
Received: 2022/08/9 | Accepted: 2022/11/20 | Published: 2023/10/29

References
1. Sikora A ZF. Nosocomial infections: StatPearls Publishing; 2021. Available from: [https://www.ncbi.nlm.nih.gov/books/NBK559312/]
2. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309-32. [DOI:10.1016/j.ajic.2008.03.002] [PMID]
3. Mohammadi M, Vaisi Raiegan A, Jalali R, Ghobadi A, Salari N, Barati H. The prevalence of nosocomial infections in Iranian hospitals. J Babol Univ Med Sci. 2019;21(1):39-45.
4. Magill SS, Edwards JR, Bamberg W,et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med.2014;370(13):1198-208. [DOI:10.1056/NEJMoa1306801] [PMID] [PMCID]
5. Monegro AF MV, Regunath H. Hospital acquired infections treasure island (FL): StatPearls Publishing; 2021 [updated 2021 Aug 30; cited 2021 Aug 1]. Available from: [https://www.ncbi.nlm.nih.gov/books/NBK441857/]
6. Geerts N, Boonen KJM, Boer AK, Scharnhorst V. Cut-off values to rule out urinary tract infection should be gender-specific. Clinica Chimica Acta. 2016;452:173-6. [DOI:10.1016/j.cca.2015.11.022] [PMID]
7. Gupta S, Malakar M, Kalita P, Pandey F. Bacterial profile and antibiograms in urinary tract infection.Al Ameen J Me Sci.2019;12(4):192-96.
8. Masajtis-Zagajewska A, Nowicki M. New markers of urinary tract infection. Clin chim Acta. 2017;471:286-91. [DOI:10.1016/j.cca.2017.06.003] [PMID]
9. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269-84. [DOI:10.1038/nrmicro3432] [PMID] [PMCID]
10. Parte A, Whitman WB, Goodfellow M, et al. Bergey's manual of systematic bacteriology: volume 5: the Actinobacteria: Springer Science & Business Media; 2012.
11. Wayne P. Clinical and laboratory standards institute. Performance standards for antimicrobial susceptibility testing.Research Gate. 2011.
12. Gessese YA, Damessa DL, Amare MM, et al. Urinary pathogenic bacterial profile, antibiogram of isolates and associated risk factors among pregnant women in Ambo town, Central Ethiopia: a cross-sectional study. Antimicrob Resist Infect Control. 2017;6(1):132. [DOI:10.1186/s13756-017-0289-6] [PMID] [PMCID]
13. Linhares I, Raposo T, Rodrigues A, Almeida A. Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000-2009). BMC Infect Dis. 2013;13(1):19. [DOI:10.1186/1471-2334-13-19] [PMID] [PMCID]
14. Medina M, Castillo-Pino E. An introduction to the epidemiology and burden of urinary tract infections. Therapeut Adv Urol. 2019;11:1756287219832172. [DOI:10.1177/1756287219832172] [PMID] [PMCID]
15. Shaifali I, Gupta U, Mahmood SE, Ahmed J. Antibiotic susceptibility patterns of urinary pathogens in female outpatients. North Am J Med Sci. 2012;4(4):163. [DOI:10.4103/1947-2714.94940] [PMID] [PMCID]
16. Alós JI. Epidemiology and etiology of community urinary infection. Antimicrobial susceptibility of major pathogens and clinical significance of resistance. Infectious Diseases and Clinical Microbiology. 2005; 23:3-8.
17. Ade-Ojo I, Oluyege A, Adegun P, Akintayo A, Aduloju O, Olofinbiyi B. Prevalence and antimicrobial susceptibility of asymptomatic significant bacteriuria among new antenatal enrollees in Southwest Nigeria. Int Res J Microbiol. 2013;4(8):197-203
18. Khanna A, Khanna M, Aggarwal A. Serratia marcescens- a rare opportunistic nosocomial pathogen and measures to limit its spread in hospitalized patients. J Clin Diagn Res. 2013;7(2):243-6. [DOI:10.7860/JCDR/2013/5010.2737] [PMID] [PMCID]
19. Kline KA, Lewis AL. Gram-positive uropathogens, polymicrobial urinary tract infection, and the emerging microbiota of the urinary tract. Microbiol Spectr. 2016;4(2):10. [DOI:10.1128/microbiolspec.UTI-0012-2012] [PMID] [PMCID]
20. Kim SY, Park Y, Kim H, et al. Rapid screening of urinary tract infection and discrimination of gram-positive and gram-negative bacteria by automated flow cytometric analysis using sysmex UF-5000. J Clin Microbiol. 2018;56(8):e02004-17. [DOI:10.1128/JCM.02004-17] [PMID] [PMCID]
21. Darbro BW, Petroelje BK, Doern GV. Lactobacillus delbrueckii as the cause of urinary tract infection. J Clin Microbiol. 2009;47(1):275-7. [DOI:10.1128/JCM.01630-08] [PMID] [PMCID]
22. Mihankhah A, Khoshbakht R, Raeisi M, Raeisi V. Prevalence and antibiotic resistance pattern of bacteria isolated from urinary tract infections in Northern Iran. J Res Med Sci 2017;2:18.
23. Ghanbari F, Khademi F, Saberianpour S, et al. An epidemiological study on the prevalence and antibiotic resistance patterns of bacteria isolated from urinary tract infections in central Iran. Avicenna J Clin Microbiol Infect. 2017;4(3):42214. [DOI:10.5812/ajcmi.42214]
24. Khoshbakht R, Salimi A, Shirzad Aski H, Keshavarzi H. Antibiotic susceptibility of bacterial strains isolated from urinary tract infections in Karaj, Iran. Jundishapour J Microbiol. 2013;6(1):86-90. [DOI:10.5812/jjm.4830]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb